CXS Therapeutics

📍 Tours, France🗓 Founded 2023👥 7 employees💰 Last funded Apr 2024
Research Services🌐 cxstherapeutics.com
Website LinkedIn
CXS Therapeutics est une plateforme de medtech impliquée dans le screening et la réaffectation (repurposing) de molécules thérapeutiques dans le cadre des maladies touchant le SNC. Les solutions sont centrées sur le patient. D’un point de vue méthodologique, l’identification des traitements d’intérêts est issue de l’utilisation d’outils transdisciplinaires et d’une exploration méthodique de la connaissance bibliographique. La finalité ? Proposer des traitements aux malades atteints de pathologies affectant le système nerveux central là où un besoin thérapeutique non satisfait demeure.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in CXS Therapeutics?
CXS Therapeutics has 1 investor on record on gritt.io, including 1 early-stage backers.
When did CXS Therapeutics last raise funding?
The most recent investment in CXS Therapeutics recorded on gritt.io was in April 2024.
When was CXS Therapeutics founded?
CXS Therapeutics was founded in 2023.
What industry is CXS Therapeutics in?
CXS Therapeutics operates in Research Services. Find similar Research Services investors on gritt.io.
Where is CXS Therapeutics based?
CXS Therapeutics is headquartered in Tours, France.